Publications‎ > ‎

Genetic epidemiology of pharmacogenetic variants in South East Asian Malays using whole genome sequences

posted Sep 30, 2016, 8:23 AM by Vinod Scaria   [ updated Oct 4, 2016, 5:26 AM ]

Expanding the scope of pharmacogenomic research by including multiple global populations is integral to building robust evidence for its clinical translation. Deep whole-genome sequencing of diverse ethnic populations provides a unique opportunity to study rare and common pharmacogenomic markers that often vary in frequency across populations. In this study, we aim to build a diverse map of pharmacogenetic variants in South East Asian (SEA) Malay population using deep whole-genome sequences of 100 healthy SEA Malay individuals. We investigated the allelic diversity of potentially deleterious pharmacogenomic variants in SEA Malay population. Our analysis revealed 227 common and 466 rare potentially functional single nucleotide variants (SNVs) in 437 pharmacogenomic genes involved in drug metabolism, transport and target genes, including 74 novel variants. This study has created one of the most comprehensive maps of pharmacogenetic markers in any population from whole genomes and will hugely benefit pharmacogenomic investigations and drug dosage recommendations in SEA Malays.

Sivadas A, Salleh MZ, Teh LK, Scaria V*
Genetic epidemiology of pharmacogenetic variants in South East Asian Malays using whole genome sequences
The Pharmacogenomics Journal (2016) doi:10.1038/tpj.2016.39